scholarly article | Q13442814 |
P356 | DOI | 10.1080/13547500802445199 |
P698 | PubMed publication ID | 18830857 |
P2093 | author name string | J Mark Skehel | |
John B Davis | |||
Allen D Roses | |||
Paul Cutler | |||
Ann M Saunders | |||
Steven M Fox | |||
David Hosford | |||
Israel S Gloger | |||
Neil A Jones | |||
Christina M Nock | |||
Emma E Kinsey | |||
Emma L Akuffo | |||
Marjorie A Smith | |||
P433 | issue | 6 | |
P921 | main subject | Alzheimer's disease | Q11081 |
(RS)-rosiglitazone | Q424771 | ||
biomarker | Q864574 | ||
P304 | page(s) | 618-636 | |
P577 | publication date | 2008-09-01 | |
P1433 | published in | Biomarkers | Q4915076 |
P1476 | title | The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone | |
P478 | volume | 13 |
Q51760901 | A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. |
Q36966044 | Alzheimer's disease: are blood and brain markers related? A systematic review |
Q37383709 | Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects |
Q33824444 | Blood-based biomarkers of Alzheimer's disease: challenging but feasible |
Q37878285 | Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? |
Q34135724 | Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions |
Q38060638 | Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer? |
Q42322507 | Microglia, Alzheimer's disease, and complement |
Q34556953 | Plasma proteins predict conversion to dementia from prodromal disease |
Q36767124 | Plasma proteomics for the identification of Alzheimer disease |
Q33804415 | Serping1/C1 Inhibitor Affects Cortical Development in a Cell Autonomous and Non-cell Autonomous Manner |
Q35191570 | Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma |
Q38060574 | Use of proteomic methods in the analysis of human body fluids in Alzheimer research |
Search more.